Insight Molecular Diagnostics Inc. Accounts Receivable, Allowance for Credit Loss
Insight Molecular Diagnostics Inc. (IMDX) had Accounts Receivable, Allowance for Credit Loss of $2.00 thousand as of 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Balance Sheet › Assets
us-gaap:AllowanceForDoubtfulAccountsReceivable · last filed 2024-05-15
- 2024-03-31: Accounts Receivable, Allowance for Credit Loss $2.00K.
- 2023-12-31: Accounts Receivable, Allowance for Credit Loss $5.00K.
- 2023-09-30: Accounts Receivable, Allowance for Credit Loss $178.00K.
- 2023-06-30: Accounts Receivable, Allowance for Credit Loss $178.00K.
| Period end | Accounts Receivable, Allowance for Credit Loss |
|---|---|
| 2024-03-31 | $2.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $5.00K 10-Q · filed 2024-05-15 |
| 2023-09-30 | $178.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $178.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $172.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $154.00K 10-K · filed 2024-04-16 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |